Endothelin is a potent vasoconstrictor peptide produced by vascular en
dothelial cells which could play a role in the physiological regulatio
n of the renal microcirculation. To test this hypothesis, experiments
were performed in 24 anaesthetized and mechanically-ventilated newborn
rabbits. In 8 newborn rabbits (group 1), a bolus injection of 5 nmol/
kg endothelin caused a marked increase in mean blood pressure (MBP) an
d renal vascular resistance (RVR), leading to a significant fall in gl
omerular filtration rate (GFR) (by 12% +/- 4%) and renal blood flow (R
BF) (by 16% +/- 3%). A second group of animals (n = 8) was used for te
sting the in vivo neutralizing activity of an endothelin-1 antiserum.
The antiserum was thereafter infused into 8 additional newborn rabbits
(group 3) in order to define the role of endogenous endothelin in mod
ulating the function of the immature kidney. The antiserum induced a s
urprising increase in RVR (by 34% +/- 9%, P <0.05) associated with a f
all in GFR (by 21% +/- 4%, P <0.05) and RBF (by 25% +/- 4%, P <0.05),
while the filtration fraction and MBP remained unchanged. The occurren
ce of a vasoconstrictive response to both high-dose endothelin and to
its antiserum could be explained by the recent demonstration that high
levels of endothelin lead to renal vasoconstriction, while lower leve
ls induce renal vasodilatation. The present results suggest that endog
enous endothelin is active at low levels under normal conditions and t
hat this peptide plays a role in the physiological control of renal fu
nction, but not MBP.